Back
Tri Pointe Homes Vs. Aligos Therapeutics Industry Stock Comparison
Sell
42
TPH
Tri Pointe Homes
Last Price:
$36.17
Seasonality Move:
-1.22%
Buy
62
ALGS
Aligos Therapeutics
Last Price:
$41.28
Seasonality Move:
-16.03%
Sell
42
Tri Pointe Homes (TPH)
is a Sell
Is Tri Pointe Homes a Buy, Sell or Hold?
-
The current Tri Pointe Homes [TPH] share price is $36.20. The Score for TPH is 42, which is 16% below its historic median score of 50, and infers higher risk than normal.
-
TPH is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
62
Aligos Therapeutics (ALGS)
is a Buy
Is Aligos Therapeutics a Buy, Sell or Hold?
-
The current Aligos Therapeutics [ALGS] share price is $41.15. The Score for ALGS is 62, which is 24% above its historic median score of 50, and infers lower risk than normal.
-
ALGS is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
TPH Stock Price Chart
What is Tri Pointe Homes's stock price today?
-
The Tri Pointe Homes share price today is $36.20Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and TPH is experiencing selling pressure, which indicates risk of future bearish movement.
ALGS Stock Price Chart
What is Aligos Therapeutics's stock price today?
-
The Aligos Therapeutics share price today is $41.15Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ALGS is experiencing slight selling pressure.
TPH Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -1.55 | Sell |
Relative Strength Index (14 RSI): | 24.67 | Sell |
Chaikin Money Flow: | -367078 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (37.69 - 43.09) | Sell |
Bollinger Bands (100): | (40.01 - 44.65) | Sell |
ALGS Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 5.69 | Buy |
Relative Strength Index (14 RSI): | 73.75 | Buy |
Chaikin Money Flow: | -154898 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (23.72 - 37.64) | Buy |
Bollinger Bands (100): | (6.81 - 25.85) | Buy |
TPH Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 36.98 | Sell |
20-day SMA: | 39.66 | Sell |
50-day SMA: | 41.23 | Sell |
200-day SMA: | 40.45 | Sell |
8-day EMA: | 37.3 | Sell |
20-day EMA: | 38.94 | Sell |
50-day EMA: | 40.71 | Sell |
200-day EMA: | 39.84 | Sell |
ALGS Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 38.54 | Buy |
20-day SMA: | 33.12 | Buy |
50-day SMA: | 21.28 | Buy |
200-day SMA: | 16.61 | Buy |
8-day EMA: | 38.79 | Buy |
20-day EMA: | 33.47 | Buy |
50-day EMA: | 25.09 | Buy |
200-day EMA: | 18.34 | Buy |
Tri Pointe Homes Earnings Growth & TPH Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.24 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.48 per share, and a decrease next year of $0.16 per share.
Aligos Therapeutics Earnings Growth & ALGS Earnings Dates
-
Analysts estimate an earnings increase this quarter of $2.02 per share, a decrease next quarter of $0.00 per share, an increase this year of $30.89 per share, and a decrease next year of $2.65 per share.
Tri Pointe Homes Technical Analysis
Dec 13 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 20 | Dec 23 | Dec 24 | Dec 26 | Dec 27 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | ||||||||||
13 | 16 | 17 | 18 | 19 | 20 | 23 | 24 | 26 | 27 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Aligos Therapeutics Technical Analysis
Dec 13 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 20 | Dec 23 | Dec 24 | Dec 26 | Dec 27 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | ||||||||||
13 | 16 | 17 | 18 | 19 | 20 | 23 | 24 | 26 | 27 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |